XML 73 R66.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Reporting - Segment Information about Reported Product Revenues, Depreciation and Amortization and Operating Income (Detail) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Product Revenues        
Product revenues $ 386,870 $ 371,512 $ 1,115,814 $ 1,103,210
Significant Segment Expenses and Operating Performance        
Cost of sales 291,722 276,639 844,439 822,883
Net research and development expenses 24,429 23,013 71,203 67,619
Selling, general and administrative expenses 42,875 36,861 122,440 116,992
Restructuring expenses, net 3,986 2,662 10,608 12,342
Loss on sale of land and building, net     2,196  
Operating income (loss) 23,858 32,337 64,928 83,374
Other segment disclosures        
Depreciation and amortization 13,389 13,352 39,478 40,085
Operating Segments        
Product Revenues        
Product revenues 386,870 371,512 1,115,814 1,103,210
Corporate and Other Unallocated Expenses        
Significant Segment Expenses and Operating Performance        
Other operating expenses 27,062 22,698 74,756 70,832
Other segment disclosures        
Depreciation and amortization 550 364 1,535 1,120
Automotive Segments        
Product Revenues        
Product revenues 374,211 358,804 1,079,937 1,067,444
Automotive Segments | Operating Segments        
Product Revenues        
Product revenues 374,211 358,804 1,079,937 1,067,444
Significant Segment Expenses and Operating Performance        
Cost of sales 283,663 267,671 822,314 800,053
Net research and development expenses 18,629 17,788 55,831 52,224
Selling, general and administrative expenses 17,013 16,127 49,546 49,765
Restructuring expenses, net 3,972 2,662 10,410 11,470
Loss on sale of land and building, net     2,196  
Operating income (loss) 50,934 54,556 139,640 153,932
Other segment disclosures        
Depreciation and amortization 11,990 12,118 35,388 36,343
Medical Segments | Operating Segments        
Product Revenues        
Product revenues 12,659 12,708 35,877 35,766
Significant Segment Expenses and Operating Performance        
Cost of sales 6,691 6,814 18,696 18,828
Restructuring expenses, net 14   170 20
Other operating expenses 5,982 5,415 17,137 16,134
Impairment of intangible assets       530
Operating income (loss) (14) 479 44 274
Other segment disclosures        
Depreciation and amortization $ 849 $ 870 2,555 2,622
Corporate Segments | Operating Segments        
Significant Segment Expenses and Operating Performance        
Restructuring expenses, net     $ 28 $ 852